Explore a next step for moderate to severe endometriosis pain relief

The first FDA-approved oral treatment for moderate to severe endometriosis pain in over a decade1,2

See how ORILISSA works

Learn how ORILISSA dials down estradiol to 2 different levels.

Available in two oral dosages:

150 mg QD   200 mg BID

Two different doses allow you to individually tailor treatment.

Dyspareunia Non-menstrual pelvic pain Dysmenorrhea
Custom HTML


A YEAR OF PATIENT EXPERIENCE

Over 10,000 HCPs have already prescribed ORILISSA for more than 30,000 patients3,4†


These data reflect the number of HCPs who have prescribed and the number of women prescribed since ORILISSA was FDA-approved. Data sourced as of September 2019 and October 2019, respectively.